TechGizmodoabout 2 hours ago
LSD Trial Succeeds for Anxiety
1 min read
Definium Therapeutics' Phase III Voyage trial showed its LSD drug DT120 significantly reduced anxiety in 214 adults with generalized anxiety disorder versus placebo. The FDA granted DT120 breakthrough therapy designation. Definium, formerly MindMed, is running further Phase III studies for depression and anxiety.
Level
Hype check
Tap to vote and see what everyone thinks.
